BIOVERATIV THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at BIOVERATIV THERAPEUTICS is $100,880, based on 26 certified filings from FY 2020 to FY 2025. This is 16% lower than the national H-1B median salary of $120,000. Compensation at BIOVERATIV THERAPEUTICS reflects their market positioning, with entry-level roles starting around $82,930 and senior positions reaching $141,149 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at BIOVERATIV THERAPEUTICS range from $60,900 at the 10th percentile to $141,149 at the 90th percentile, showing a $80,249 spread across experience levels and roles. The 25th percentile is $82,930 and the 75th percentile is $118,000.

Yes, BIOVERATIV THERAPEUTICS actively sponsors H-1B visas in FY 2025. In the most recent fiscal year (FY 2025), BIOVERATIV THERAPEUTICS filed 2 H-1B labor condition applications with 2 certified and 0 denied, at a median salary of $104,416. Across FY 2020–2025, they have filed 28 total H-1B applications with 26 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. BIOVERATIV THERAPEUTICS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), BIOVERATIV THERAPEUTICS filed 2 H-1B applications, with 2 certified and 0 denied. Over 5 years of data, BIOVERATIV THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

BIOVERATIV THERAPEUTICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 28 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating BIOVERATIV THERAPEUTICS as a potential H-1B sponsor.

This is an excellent approval rate, indicating BIOVERATIV THERAPEUTICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

BIOVERATIV THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 26 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles BIOVERATIV THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at BIOVERATIV THERAPEUTICS:

The most frequently sponsored role is Research Scientist with 6 filings at a median salary of $101,026. This is followed by Associate Research Scientist (3 filings) and Senior Research Scientist.

BIOVERATIV THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where BIOVERATIV THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top BIOVERATIV THERAPEUTICS H-1B locations:

The largest H-1B hub for BIOVERATIV THERAPEUTICS is Waltham, MA with 20 filings at a median salary of $82,930. The highest-paying location is Cambridge, MA at $101,026 median. Salaries range from $82,930 to $101,026 across office locations.

BIOVERATIV THERAPEUTICS's median H-1B salary has increased by +26% from FY 2020 ($82,930) to FY 2025 ($104,416). Tracking salary trends over time reveals how BIOVERATIV THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at BIOVERATIV THERAPEUTICS.

Year-by-year breakdown:

• FY 2020: $82,930 (13 certified)
• FY 2021: $116,896 (5 certified)
• FY 2022: $84,448 (1 certified)
• FY 2023: $132,434 (5 certified)
• FY 2025: $104,416 (2 certified)

This 26% growth reflects strong compensation adjustments at BIOVERATIV THERAPEUTICS, keeping pace with market demands for H-1B talent.

BIOVERATIV THERAPEUTICS primarily files H-1B applications at Wage Level II, accounting for 42% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making BIOVERATIV THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

BIOVERATIV THERAPEUTICS has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

BIOVERATIV THERAPEUTICS's median H-1B salary of $100,880 is 16% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating BIOVERATIV THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare BIOVERATIV THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

BIOVERATIV THERAPEUTICS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. BIOVERATIV THERAPEUTICS files 29% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 26 certified filings, BIOVERATIV THERAPEUTICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.